These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide. Sacks FM; Stanesa M; Hegele RA JAMA Intern Med; 2014 Mar; 174(3):443-7. PubMed ID: 24366202 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS). Jones A; Peers K; Wierzbicki AS; Ramachandran R; Mansfield M; Dawson C; Ochoa-Ferraro A; Soran H; Jenkinson F; McDowell I; Downie P; Hamilton P; Jones RD Atherosclerosis; 2023 Jun; 375():67-74. PubMed ID: 37253281 [TBL] [Abstract][Full Text] [Related]
7. Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome. Paquette M; Amyot J; Fantino M; Baass A; Bernard S J Clin Endocrinol Metab; 2021 Aug; 106(9):e3473-e3482. PubMed ID: 34019660 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of therapeutic plasma exchange in reducing the incidence of recurrent pancreatitis related to familial chylomicronemia. Fitts E; Lee PDK; Yates SG Transfusion; 2019 Nov; 59(11):3324-3328. PubMed ID: 31568575 [TBL] [Abstract][Full Text] [Related]
9. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia. Baass A; Paquette M; Bernard S; Hegele RA J Intern Med; 2020 Apr; 287(4):340-348. PubMed ID: 31840878 [TBL] [Abstract][Full Text] [Related]
10. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score". Moulin P; Dufour R; Averna M; Arca M; Cefalù AB; Noto D; D'Erasmo L; Di Costanzo A; Marçais C; Alvarez-Sala Walther LA; Banach M; Borén J; Cramb R; Gouni-Berthold I; Hughes E; Johnson C; Pintó X; Reiner Ž; van Lennep JR; Soran H; Stefanutti C; Stroes E; Bruckert E Atherosclerosis; 2018 Aug; 275():265-272. PubMed ID: 29980054 [TBL] [Abstract][Full Text] [Related]
11. Volanesorsen for treatment of familial chylomicronemia syndrome. Lazarte J; Hegele RA Expert Rev Cardiovasc Ther; 2021 Aug; 19(8):685-693. PubMed ID: 34261380 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of therapies for chylomicronemia. Shamsudeen I; Hegele RA Expert Rev Clin Pharmacol; 2022 Apr; 15(4):395-405. PubMed ID: 35762447 [TBL] [Abstract][Full Text] [Related]
13. The burden of familial chylomicronemia syndrome in Canadian patients. Gaudet D; Stevenson M; Komari N; Trentin G; Crowson C; Hadker N; Bernard S Lipids Health Dis; 2020 Jun; 19(1):120. PubMed ID: 32487261 [TBL] [Abstract][Full Text] [Related]
14. Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study. Blom DJ; O'Dea L; Digenio A; Alexander VJ; Karwatowska-Prokopczuk E; Williams KR; Hemphill L; Muñiz-Grijalvo O; Santos RD; Baum S; Witztum JL J Clin Lipidol; 2018; 12(5):1234-1243.e5. PubMed ID: 30318066 [TBL] [Abstract][Full Text] [Related]
15. Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial. Witztum JL; Gaudet D; Arca M; Jones A; Soran H; Gouni-Berthold I; Stroes ESG; Alexander VJ; Jones R; Watts L; Xia S; Tsimikas S J Clin Lipidol; 2023; 17(3):342-355. PubMed ID: 37100699 [TBL] [Abstract][Full Text] [Related]
16. Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia. Kolovou G; Diakoumakou O; Kolovou V; Fountas E; Stratakis S; Zacharis E; Liberopoulos EN; Matsouka F; Tsoutsinos A; Mastorakou I; Katsikas T; Mavrogeni S; Hatzigeorgiou G Eur J Prev Cardiol; 2020 Jan; 27(2):157-165. PubMed ID: 31403880 [TBL] [Abstract][Full Text] [Related]
17. Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report. Makhmudova U; Schulze PC; Lorkowski S; März W; Geiling JA; Weingärtner O J Med Case Rep; 2024 Jun; 18(1):278. PubMed ID: 38872171 [TBL] [Abstract][Full Text] [Related]
18. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis. Chyzhyk V; Brown AS Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756 [TBL] [Abstract][Full Text] [Related]
19. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists. Falko JM Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397 [TBL] [Abstract][Full Text] [Related]